We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Medicines Co. Gets Fed. Circ. Grilling On Blood Thinner IP

Law360, Washington (December 6, 2016, 3:31 PM EST) -- Members of a Federal Circuit panel questioned whether The Medicines Co. could hold onto one of its patents on the blood thinning drug Angiomax Tuesday, wondering whether the patent was so...
To view the full article, register now.